Oral Cavity Squamous Cell Carcinoma — Trials

Oral Cavity Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

264 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 83
Recruiting: 37
Ph III recruiting: 8
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00030498	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	completed	Phase 1	75	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials
NCT01637194	Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer	completed	Phase 1	12	Fox Chase Cancer CenterOTHER	1	Jul 11, 2012	clinicaltrials